To assess whether tumor inherent interferons can actually drive chemotherapeutic sensitivity and a hot TME, we enhanced IFN production and signaling in highly metastatic murine 4T1.2 TNBC cells via enforced expression of the master regulator of IFN production—IRF7 (a target of IRF9). Here, IRF9 is linked to neoplasm.